Immuneering Granted FDA Fast Track Designation for IMM-1-104 in Advanced Melanoma
Immuneering (IMRX) GlobeNewswire News Room·2024-12-12 21:00Immuneering (IMRX) GlobeNewswire News Room·2024-12-12 21:00
R1Immuneering (IMRX) GlobeNewswire News Room·2024-12-12 21:00